Using translational approaches that encompass genomic studies, biomarker development, disease modeling, natural history studies, and clinical trials, Dr. Vanderver seeks to improve the quality of life and lifespan of individuals living with leukodystrophies or heritable disorder of myelin. She leads the Leukodystrophy Center of Excellence at Children's Hospital of Philadelphia.
Maria Kefalas and Pat Carr, and Matt and Lauren Hammond, two families affected by leukodystrophy, presented a check of $110,000 on behalf of The Calliope Joy Foundation to Children’s Hospital of Philadelphia (CHOP) at the Loie Hammond Memorial Lectureship held on January 25, 2018.
The Research Institute's commitment to cultivating and producing strong scientific research is grounded in the diverse mix of experiences, talents, and perspectives that our researchers contribute to our success.
"Diversity has long been a key driver of achievement at Children's Hospital of Philadelphia's Research Institute, particularly when it comes to innovation and performing more accurate and inclusive research," wrote Bryan
Looking at a scientific problem from new and different perspectives is what research is all about, which is why Children's Hospital of Philadelphia's Research Institute is dedicated to cultivating a more diverse workforce. "We value diversity within our research community and it is undoubtedly part of what makes us successful," wrote Bryan A. Wolf, MD, PhD, Chief Scientific Officer and Director